"Thiazolidinediones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
THIAZOLES with two keto oxygens. Members are insulin-sensitizing agents which overcome INSULIN RESISTANCE by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma).
Descriptor ID |
D045162
|
MeSH Number(s) |
D02.886.675.933 D03.383.129.708.933
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thiazolidinediones".
Below are MeSH descriptors whose meaning is more specific than "Thiazolidinediones".
This graph shows the total number of publications written about "Thiazolidinediones" by people in this website by year, and whether "Thiazolidinediones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 2 | 0 | 2 |
2004 | 4 | 0 | 4 |
2005 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2007 | 1 | 3 | 4 |
2008 | 1 | 0 | 1 |
2010 | 3 | 1 | 4 |
2011 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2015 | 2 | 0 | 2 |
2016 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thiazolidinediones" by people in Profiles.
-
Prospective Postmarketing Surveillance of Acute Myocardial Infarction in New Users of Saxagliptin: A Population-Based Study. Diabetes Care. 2018 01; 41(1):39-48.
-
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study. Ann Intern Med. 2016 Jun 07; 164(11):705-14.
-
Pioglitazone Use and Risk of Bladder Cancer--Reply. JAMA. 2015 Dec 15; 314(23):2568-9.
-
Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes. JAMA. 2015 Jul 21; 314(3):265-77.
-
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):636-45.
-
HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings. Diabetologia. 2014 Feb; 57(2):334-8.
-
Initiation of insulin among veterans with type 2 diabetes and sustained elevation of A1c. Prim Care Diabetes. 2012 Apr; 6(1):19-25.
-
Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care. 2011 Apr; 34(4):916-22.
-
Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
-
Thiazolidinediones and fractures: evidence from translating research into action for diabetes. J Clin Endocrinol Metab. 2010 Oct; 95(10):4560-5.